Skip to main content

Stereotaxis, Inc.

For the period ended Sep 30, 2025. Filed Nov 12, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 12, 2025

STXS$1.03-9.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

Nine Months Ended September 30,
(in thousands) · 2025 · 2024
Cash flows from operating activities
Net loss$(16,112)$(16,530)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation468428
Amortization of intangibles692178
Loss on revaluation of contingent consideration1,810672
Non-cash lease expense17
Stock-based compensation7,4057,696
Changes in operating assets and liabilities:
Accounts receivable(1,509)(3,401)
Inventories(1,816)619
Prepaid expenses and other current assets1,171(177)
Other assets(173)21
Accounts payable(1,015)1,448
Accrued liabilities93364
Deferred revenue(722)(1,100)
Other liabilities(9)12
Net cash used in operating activities(9,716)(9,763)
Cash flows from investing activities
Purchase of property and equipment(23)(32)
Cash acquired in business acquisitions-108
Net cash (used in) provided by investing activities(23)76
Cash flows from financing activities
Proceeds from issuance of stock, net of issuance costs7,809138
Net cash provided by financing activities7,809138
Net decrease in cash, cash equivalents, and restricted cash(1,930)(9,549)
Cash, cash equivalents, and restricted cash at beginning of period12,43620,562
Cash, cash equivalents, and restricted cash at end of period$10,506$11,013
Supplemental disclosure of cash flow information:
Purchase of property and equipment included in accounts payable$27$-
Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheet as of September 30th:
Cash and cash equivalents$10,506$10,663
Restricted cash - current-350
Total cash, cash equivalents, and restricted cash$10,506$11,013
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.